Importance of Carbapenemase Production Detection in Carbapenem-Resistant Enterobacteriaceae: Looking Beyond Epidemiological Purposes

To the Editor—We read with great interest the recent article by Tamma et al [1], who reported that patients with carbapenemase-producing carbapenem-resistant Enterobacteriaceae (CP-CRE) have 2.6 and 4.9 higher odds for bacteremia recurrence at 30 days and mortality at 14 days, respectively, compared with patients with non-CP CRE.